Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
28.43
+1.41 (5.22%)
At close: Jun 26, 2026, 4:00 PM EDT
28.99
+0.56 (1.97%)
After-hours: Jun 26, 2026, 6:16 PM EDT
Maze Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Maze Therapeutics stock have an average target of 63, with a low estimate of 46 and a high estimate of 110. The average target predicts an increase of 121.60% from the current stock price of 28.43.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Maze Therapeutics stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 11 | 11 | 11 | 11 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $97 | Buy | Maintains | $97 | +241.19% | Jun 23, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $110 | Buy | Reiterates | $110 | +286.92% | Jun 22, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $58 → $53 | Buy | Maintains | $58 → $53 | +86.42% | May 23, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $57 | Buy | Maintains | $57 | +100.49% | May 16, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |
Financial Forecast
Revenue This Year
20.00M
Revenue Next Year
8.85M
from 20.00M
Decreased by -55.77%
EPS This Year
-2.67
from -3.05
EPS Next Year
-3.19
from -2.67
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 40.0M | 60.0M | |
| Avg | 20.0M | 8.8M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 200.0% | 465.3% |
| Avg | -55.8% | -6.1% |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.00 | -2.33 | |
| Avg | -2.67 | -3.19 | |
| Low | -3.07 | -4.68 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.